In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
University of Southern California
University of Southern California
Mayo Clinic
Medicenna Therapeutics, Inc.
UNICANCER
Massachusetts General Hospital
Genzada Pharmaceuticals USA, Inc.
Xencor, Inc.
Dartmouth-Hitchcock Medical Center
Case Comprehensive Cancer Center